These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18767161)

  • 21. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.
    Matsui K; Boniface JJ; Steffner P; Reay PA; Davis MM
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12862-6. PubMed ID: 7809136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinations of affinity-enhancing mutations in a T cell receptor reveal highly nonadditive effects within and between complementarity determining regions and chains.
    Pierce BG; Haidar JN; Yu Y; Weng Z
    Biochemistry; 2010 Aug; 49(33):7050-9. PubMed ID: 20681514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex.
    Harris DT; Wang N; Riley TP; Anderson SD; Singh NK; Procko E; Baker BM; Kranz DM
    J Biol Chem; 2016 Nov; 291(47):24566-24578. PubMed ID: 27681597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of MHC-CD8 interaction at the T cell membrane.
    Huang J; Edwards LJ; Evavold BD; Zhu C
    J Immunol; 2007 Dec; 179(11):7653-62. PubMed ID: 18025211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MM-GBSA binding free energy decomposition and T cell receptor engineering.
    Zoete V; Irving MB; Michielin O
    J Mol Recognit; 2010; 23(2):142-52. PubMed ID: 20151417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular recognition of diverse ligands by T-cell receptors.
    Sundberg EJ
    Methods Mol Biol; 2009; 524():347-59. PubMed ID: 19377957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor.
    Stone JD; Chervin AS; Schreiber H; Kranz DM
    Biotechnol Prog; 2012; 28(6):1588-97. PubMed ID: 22961781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATLAS: A database linking binding affinities with structures for wild-type and mutant TCR-pMHC complexes.
    Borrman T; Cimons J; Cosiano M; Purcaro M; Pierce BG; Baker BM; Weng Z
    Proteins; 2017 May; 85(5):908-916. PubMed ID: 28160322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models.
    Margulies DH
    Curr Opin Immunol; 1997 Jun; 9(3):390-5. PubMed ID: 9203420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cellular environment regulates in situ kinetics of T-cell receptor interaction with peptide major histocompatibility complex.
    Liu B; Chen W; Natarajan K; Li Z; Margulies DH; Zhu C
    Eur J Immunol; 2015 Jul; 45(7):2099-110. PubMed ID: 25944482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.
    Audehm S; Glaser M; Pecoraro M; Bräunlein E; Mall S; Klar R; Effenberger M; Albers J; Bianchi HO; Peper J; Yusufi N; Busch DH; Stevanović S; Mann M; Antes I; Krackhardt AM
    Front Immunol; 2019; 10():1485. PubMed ID: 31316521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evolution of a T cell receptor with high affinity for peptide/MHC.
    Holler PD; Holman PO; Shusta EV; O'Herrin S; Wittrup KD; Kranz DM
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5387-92. PubMed ID: 10779548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?
    Mareeva T; Lebedeva T; Anikeeva N; Manser T; Sykulev Y
    J Biol Chem; 2004 Oct; 279(43):44243-9. PubMed ID: 15302863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell receptor structure and TCR complexes.
    Wilson IA; Garcia KC
    Curr Opin Struct Biol; 1997 Dec; 7(6):839-48. PubMed ID: 9434905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for self-recognition by autoimmune T-cell receptors.
    Yin Y; Li Y; Mariuzza RA
    Immunol Rev; 2012 Nov; 250(1):32-48. PubMed ID: 23046121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific increase in potency via structure-based design of a TCR.
    Malecek K; Grigoryan A; Zhong S; Gu WJ; Johnson LA; Rosenberg SA; Cardozo T; Krogsgaard M
    J Immunol; 2014 Sep; 193(5):2587-99. PubMed ID: 25070852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of maximal affinities between T-cell receptors and MHC/peptide complexes.
    Salzmann M; Bachmann MF
    Mol Immunol; 1998 Feb; 35(2):65-71. PubMed ID: 9683252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.
    Maenaka K; Juji T; Nakayama T; Wyer JR; Gao GF; Maenaka T; Zaccai NR; Kikuchi A; Yabe T; Tokunaga K; Tadokoro K; Stuart DI; Jones EY; van der Merwe PA
    J Biol Chem; 1999 Oct; 274(40):28329-34. PubMed ID: 10497191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.